6
Oct
2026
9
Nov
2027
CZECH-GEN
About CZECH-GEN
Certifications
Categories
-
Country/Region:Czech Republic
-
Founded:1992
-
On CPHI since:2015
-
Certificates:4
-
Employees:250 - 499
Company types
Primary activities
Products from CZECH-GEN (17)
-
Product Brimonidin Tartrate
Brimonidine Tartrate – API for Ophthalmic and Dermatological Applications
Brimonidine Tartrate is a selective alpha-2 adrenergic receptor agonist used in pharmaceutical formulations for:
• -Treatment of glaucoma and ocular hypertension
• -Symptomatic treatment of facial erythema ass... -
Product Bromfenac Sodium (Sesquihydrate)
Bromfenac Sodium – NSAID for Ophthalmic Applications
Bromfenac Sodium is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes, reducing prostaglandin synthesis and helping control ocular inflammation and pain.
Therapeutic Applications:
• -Tr... -
Product Alfuzosin hydrochloride (CEP grade)
Alfuzosin Hydrochloride – API for Urological Applications
Alfuzosin hydrochloride is an alpha-1 adrenergic receptor antagonist that relaxes smooth muscle in the prostate and bladder neck, improving urination and relieving urinary symptoms.
Therapeutic Applications: Treatment of benign pros... -
Product Brimonidine tartrate (CEP grade)
Brimonidine Tartrate – API for Ophthalmic and Dermatological Applications
Brimonidine Tartrate is a selective alpha-2 adrenergic receptor agonist used in pharmaceutical formulations for:
• Treatment of glaucoma and ocular hypertension
• Symptomatic treatment of facial erythema assoc... -
Product Butamirate citrate
Butamirate Citrate – API for Respiratory Applications
Butamirate Citrate is a centrally acting, non-opioid antitussive agent that suppresses the cough reflex without causing opioid-related dependence.
Therapeutic Applications: Symptomatic treatment of dry, non-productive cough
M... -
Product Dofetilide
Dofetilide – Antiarrhythmic API
Dofetilide is an active pharmaceutical ingredient (API) belonging to the class of Class III antiarrhythmic agents, acting as a selective blocker of cardiac potassium channels.
Therapeutic Applications: Maintenance of normal sinus rhythm in patients with... -
Product Chlorprothixene hydrochloride
Chlorprothixene Hydrochloride – API for Psychiatric Applications
Chlorprothixene Hydrochloride is an active pharmaceutical ingredient (API) belonging to the thioxanthene class of first-generation antipsychotics.
Therapeutic Applications:
• Schizophrenia and other psychotic disorders q... -
Product Eszopiclone
Eszopiclone – API for Insomnia Treatment
Eszopiclone is an active pharmaceutical ingredient (API) belonging to the class of non-benzodiazepine hypnotics that act as positive allosteric modulators of GABA-A receptors.
Therapeutic Application: Treatment of insomnia... -
Product Moxonidine (CEP grade)
Moxonidine – API for Hypertension Treatment
Moxonidine is an active pharmaceutical ingredient (API) belonging to the class of centrally acting imidazoline I1-receptor agonists.
Therapeutic Application: Treatment of essential hypertension
Manufactured ... -
Product Regadenoson
Regadenoson – API for Cardiac Stress Testing
Regadenoson is an active pharmaceutical ingredient (API) belonging to the class of selective adenosine A2A receptor agonists.
Diagnostic Application: Pharmacological stress testing for myocardial perfusion imaging (MPI) in patients unable t... -
Product Riluzole
Riluzole – API for Neurological Applications
Riluzole is an active pharmaceutical ingredient (API) belonging to the class of glutamatergic modulators with neuroprotective properties.
Therapeutic Application: Treatment of amyotrophic lateral sclerosis (ALS) to extend survival or delay ... -
Product Tizanidine hydrochloride
Tizanidine Hydrochloride – API for Muscle Relaxant Applications
Tizanidine Hydrochloride is an active pharmaceutical ingredient (API) belonging to the class of centrally acting α2-adrenergic receptor agonists.
Therapeutic Application: Management of muscle spasticity, including increas...
CZECH-GEN Resources (1)
-
Brochure FARMAK Presentation
FARMAK Presentation 2020
















